missense mutation
Chromosome 7
8
p.V600D
-
Chromosome 7
-
I
The V600 is the most frequently reported BRAF missense mutation in which the amino acid is substituted at position 600 of BRAF(PMID: 21639808; 21129611). This mutation occurs within the activation segment of the kinase domain (exon 15). BRAF V600E mutations are associated with increased sensitivity to BRAF inhibitors (PMID: 21639808; 22805292; 24445759; 22735384; 22356324). Vemurafenib, dabrafenib and trametinib have been aproved by the FDA for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E.
This section displays the distribution of mutated samples and tissue types (top 5).
Cancer | DISSECT gene frequence | DISSECT variant frequence | COSMIC gene frequence | COSMIC variant frequence |
---|---|---|---|---|
Skin cancer | 0.3225 | 0.0018 | - | - |
Colorectal cancer | 0.1692 | - | - | - |
Lung cancer | 0.0451 | - | - | - |
Bladder cancer | 0.0301 | - | - | - |
Prostate cancer | 0.0128 | - | - | - |
Cancer | Durg | Drug type | Drug groups | Evidence level |
---|---|---|---|---|
Melanoma | Dabrafenib | Small Molecule | Approved | A |